Product
POLB 001
1 clinical trial
2 indications
Indication
InfluenzaIndication
HumanClinical trial
A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate Safety, PK and the Immunosuppressive Effects of p38 MAPK Inhibitor POLB 001 on the Intradermal and Intravenous LPS Challenge Response in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-12-14